INmune Bio, Inc. (INMB)
1.21
0.00 (0.00%)
USD |
NASDAQ |
Apr 06, 09:50
INmune Bio Total Liabilities (Quarterly) : 8.827M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AngioDynamics, Inc. | 87.32M |
| Omeros Corp. | 446.86M |
| Precipio, Inc. | 6.756M |
| PDS Biotechnology Corp. | 21.28M |
| Sangamo Therapeutics, Inc. | 74.78M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 32.35M |
| Shareholders Equity (Quarterly) | 23.52M |
| Debt to Equity Ratio | 0.044 |
| Current Ratio | 3.551 |
| Net Debt Paydown Yield | 0.91% |